Clinical Outcomes of Melanoma Brain Metastases Treated With Stereotactic Radiation and Anti-PD-1 Therapy

被引：5
|
作者：
Ahmed, K. A. [1 ]
Stallworth, D. G. [1 ]
Johnstone, P. A. S. [1 ]
Harrison, L. B. [1 ]
Etame, A. B. [1 ]
Weber, J. S. [1 ]
Gibney, G. T. [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
126
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [41] Outcomes of melanoma brain metastases treated with stereotactic radiosurgery with and without concurrent immune checkpoint therapy.
    Yang, Jessica
    Dercle, Laurent
    Yaeh, Andrew M.
    Yeh, Randy
    Manson, Daniel K.
    Saad, Shumaila
    Jeffrey, Bruce N.
    Sisti, Michael B.
    McKhann, Guy M.
    Wang, Tony J. C.
    Schwartz, Lawrence H.
    Carvajal, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Volume of Disease as a Predictor for Clinical Outcomes in Patients with Melanoma Brain Metastases Treated with Stereotactic Radiosurgery and Immunotherapy
    Burke, A. M.
    Carrasquilla, M.
    Jean, W. C.
    Collins, B. T.
    Anaizi, A.
    Atkins, M. B.
    Gibney, G.
    Collins, S. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E113 - E114
  • [43] Resistance patterns to anti-PD-1 therapy in metastatic melanoma
    Ozgun, Alpaslan
    Sondak, Vernon K.
    Markowitz, Joseph
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (06)
  • [44] Clinical Outcomes of Combined BRAF and MEK Inhibition With Stereotactic Radiation for BRAF Mutant Melanoma Brain Metastases
    Echevarria, M.
    Ahmed, K. A.
    Patel, B.
    Abuodeh, Y. A.
    Naghavi, A. O.
    Sarangkasiri, S.
    Johnstone, P. A. S.
    Etame, A. B.
    Yu, H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E115 - E116
  • [45] Stereotactic Radiation Therapy for Brain Metastases: Factors Affecting Outcomes and Radiation Necrosis
    Barillaro, Angela
    Caroprese, Mara
    Cella, Laura
    Viggiano, Anna
    Buccelli, Francesca
    Daponte, Chiara
    Feoli, Chiara
    Oliviero, Caterina
    Clemente, Stefania
    Farella, Antonio
    Conson, Manuel
    Pacelli, Roberto
    CANCERS, 2023, 15 (07)
  • [46] Comprehensive molecular and clinical characterization of Asian melanoma patients treated with anti-PD-1 antibody
    Lee, Jiyun
    Lee, Su Jin
    Kim, Kyung
    Kim, Seung Tae
    Lee, Jeeyun
    BMC CANCER, 2019, 19 (01)
  • [47] Comprehensive molecular and clinical characterization of Asian melanoma patients treated with anti-PD-1 antibody
    Jiyun Lee
    Su Jin Lee
    Kyung Kim
    Seung Tae Kim
    Kee-Taek Jang
    Jeeyun Lee
    BMC Cancer, 19
  • [48] Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma
    Patrinely, James R., Jr.
    Baker, Laura X.
    Davis, Elizabeth J.
    Song, Haocan
    Ye, Fei
    Johnson, Douglas B.
    CANCER, 2020, 126 (15) : 3448 - 3455
  • [49] Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma
    Schvartsman, Gustavo
    Ma, Junsheng
    Bassett, Roland L., Jr.
    Haydu, Lauren E.
    Amaria, Rodabe Navroze
    Hwu, Patrick
    Wong, Michael K.
    Hwu, Wen-Jen
    Diab, Adi
    Patel, Sapna Pradyuman
    Davies, Michael A.
    Hamerschlak, Nelson
    Tawbi, Hussein Abdul-Hassan
    Oliva, Isabella C. Glitza
    CANCER, 2019, 125 (23) : 4193 - 4202
  • [50] The Impact of Targeted Therapy and Immunotherapy on Melanoma Brain Metastases Treated With Stereotactic Radiosurgery
    Paulsson, A. K.
    Garcia, M. A.
    Tinkle, C. L.
    Nakamura, J. L.
    Fogh, S. E.
    Sneed, P. K.
    Braunstein, S. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E108 - E108
12345